Brief: Demant to sell Oticon Medical to Impilo

Demant A/S

22/10/2025 06:00

Oct 22 (Reuters) - Demant A/S DEMANT.CO:

SAID ON TUESDAY IT HAS SIGNED AN AGREEMENT TO SELL OTICON MEDICAL TO IMPILO

TOTAL CONTRACTUAL CONSIDERATION OF UP TO DKK 600 MILLION

WITH SALE CONCLUDES DIVESTMENT OF HEARING IMPLANTS BUSINESS AREA

SUBJECT TO NET WORKING CAPITAL AND NET DEBT ADJUSTMENTS, DKK 325 MILLION WILL BE PAID IN CASH AT CLOSING

REMAINING PAYMENT CONTINGENT UPON ACHIEVEMENT OF CERTAIN TARGETS AND MILESTONES IN THE COMING YEARS

THE PROCEEDS FROM THE DIVESTMENT WILL BE ADDED TO THE GROUP’S CASH RESERVES AND REDUCE THE GROUP’S GEARING MULTIPLE

CLOSING OF THE TRANSACTION IS EXPECTED TO TAKE PLACE NO LATER THAN THE END OF Q1 2026

 Source text
 Further company coverage: DEMANT.CO

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))